Show simple item record

2010-10-14Zeitschriftenartikel DOI: 10.25646/662
Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe
dc.contributor.authorKöck, Robin
dc.contributor.authorBecker, Karsten
dc.contributor.authorCookson, B.
dc.contributor.authorGemert-Pijnen, J. E. van
dc.contributor.authorHarbarth, S.
dc.contributor.authorKluytmans, J.
dc.contributor.authorMielke, Martin
dc.contributor.authorPeters, G.
dc.contributor.authorSkov, R. L.
dc.contributor.authorStruelens, M. J.
dc.contributor.authorTacconelli, E.
dc.contributor.authorTorné, A. Navarro
dc.contributor.authorWitte, Wolfgang
dc.contributor.authorFriedrich, Alexander W.
dc.date.accessioned2018-05-07T14:10:48Z
dc.date.available2018-05-07T14:10:48Z
dc.date.created2010-11-15
dc.date.issued2010-10-14none
dc.identifier.otherhttp://edoc.rki.de/oa/articles/reQfV653FoTk/PDF/24yUoIhri9vmw.pdf
dc.identifier.urihttp://edoc.rki.de/176904/737
dc.description.abstractMethicillin-resistant Staphylococcus aureus (MRSA) is a major cause of healthcare- and community-associated infections worldwide. Within the healthcare setting alone, MRSA infections are estimated to affect more than 150,000 patients annually in the European Union (EU), resulting in attributable extra in-hospital costs of EUR 380 million for EU healthcare systems. Pan-European surveillance data on bloodstream infections show marked variability among EU Member States in the proportion of S. aureus that are methicillin-resistant, ranging from less than 1% to more than 50%. In the past five years, the MRSA bacteraemia rates have decreased significantly in 10 EU countries with higher endemic rates of MRSA infections. In addition to healthcare-associated infections, new MRSA strains have recently emerged as community- and livestock-associated human pathogens in most EU Member States. The prevention and control of MRSA have therefore been identified as public health priorities in the EU. In this review, we describe the current burden of MRSA infections in healthcare and community settings across Europe and outline the main threats caused by recent changes in the epidemiology of MRSA. Thereby, we aim at identifying unmet needs of surveillance, prevention and control of MRSA in Europe.eng
dc.language.isoeng
dc.publisherRobert Koch-Institut
dc.subjectAnimalseng
dc.subjectHumanseng
dc.subjectPopulation Surveillanceeng
dc.subjectRisk Factorseng
dc.subjectEurope/epidemiologyeng
dc.subjectCross Infection/microbiologyeng
dc.subjectCross Infection/epidemiologyeng
dc.subjectCommunity-Acquired Infections/epidemiologyeng
dc.subjectCommunity-Acquired Infections/microbiologyeng
dc.subjectStaphylococcal Infections/epidemiologyeng
dc.subjectStaphylococcal Infections/microbiologyeng
dc.subjectBacteremia/economicseng
dc.subjectBacteremia/epidemiologyeng
dc.subjectBacteremia/microbiologyeng
dc.subjectBacteremia/prevention & controleng
dc.subjectCommunity-Acquired Infections/economicseng
dc.subjectCommunity-Acquired Infections/prevention & controleng
dc.subjectCross Infection/economicseng
dc.subjectCross Infection/prevention & controleng
dc.subjectHospital Costseng
dc.subjectLength of Stayeng
dc.subjectMethicillin-Resistant Staphylococcus aureuseng
dc.subjectStaphylococcal Infections/economicseng
dc.subjectStaphylococcal Infections/prevention & controleng
dc.subject.ddc610 Medizin
dc.titleMethicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe
dc.typeperiodicalPart
dc.identifier.urnurn:nbn:de:0257-10011349
dc.identifier.doihttp://dx.doi.org/10.25646/662
local.edoc.container-titleEuroSurveillance
local.edoc.fp-subtypeArtikel
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttp://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19688
local.edoc.container-publisher-nameECDC
local.edoc.container-volume15
local.edoc.container-issue41
local.edoc.container-year2010

Show simple item record